Physician profile
Paul Shepherd
NPI 1558648279
$1,668.28
in general payments reported to CMS, 2019-2025
19 companies · $424 in 2025
The $424 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $114 · 2021: $54.54 · 2022: $211 · 2023: $505 · 2024: $190 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,119.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $421.96 | 2022-2024 | Tyrvaya |
| Alcon Vision LLC | $203.97 | 2019-2025 | Rocklatan, Tryptyr, Eysuvis |
| Johnson & Johnson Vision Care, INC. | $191.59 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $187.99 | 2022-2025 | Miebo, Infuse, Xiidra |
| Sun Pharmaceutical Industries INC. | $165.27 | 2019-2022 | |
| Ocular Therapeutix, INC. | $99.55 | 2025 | |
| Hoffmann-La Roche Limited | $69.10 | 2019 | |
| Coopervision INC. | $61.48 | 2022-2025 | Clariti Contact Lens, Myday Contact Lens |
| Dompe US, INC. | $50.06 | 2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $41.54 | 2020-2023 | |
| Maculogix, INC. | $24.69 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $22.31 | 2019 | |
| Thea Pharma INC. | $22.00 | 2024 | Iyuzeh |
| Johnson & Johnson Surgical Vision, INC. | $20.76 | 2020 | |
| Allergan, INC. | $19.99 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abb Con-Cise Optical Group LLC | $18.50 | 2022 | |
| Abbvie INC. | $16.64 | 2022 | |
| Kala Pharmaceuticals, INC. | $16.63 | 2021 | |
| Aerie Pharmaceuticals, INC. | $14.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Shepherd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.